Eko Analysis Software vs KardiaAI
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if you utilize Eko digital stethoscopes and require an integrated solution for real-time auscultation and simultaneous ECG analysis. It is ideal for clinicians seeking AI-powered assistance in the early detection of heart murmurs and atrial fibrillation directly during patient examinations or remote monitoring, offering both heart sound and ECG visualization.
View Eko Analysis Software →Choose KardiaAI if…
Choose KardiaAI if your primary need is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms across a broad range of cardiac conditions. This tool is best suited for integrating advanced AI-powered ECG interpretation into existing mobile apps, web platforms, or other ECG devices to detect conditions like AFib, bradycardia, tachycardia, and various ectopies, providing a flexible API for developers.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | Unknown | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software offers a more integrated and intuitive user experience by seamlessly combining its digital stethoscopes with a mobile app for both auscultation and ECG capabilities. While KardiaAI's app is widely used, some user feedback indicates a paywall-heavy experience for essential features and occasional difficulties in obtaining consistent readings, which can detract from overall usability.
Clinical Value
KardiaAIKardiaAI provides a broader and deeper range of ECG rhythm and morphology detections, with its FDA-cleared algorithms capable of detecting up to 35 rhythms and morphologies, including specific conditions like PVCs, Wide QRS, and SVE. While Eko excels in combining auscultation with ECG and has strong validation for murmur detection, KardiaAI's extensive ECG analysis capabilities offer more comprehensive diagnostic insights from ECGs alone.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software offers a freemium model, providing access to basic app features and a complimentary trial of its advanced AI capabilities with a stethoscope purchase, before requiring an annual Eko+ membership at $119.99 (US). In contrast, KardiaAI's app is criticized by users for locking many basic functionalities behind a subscription, diminishing its perceived value despite transparent pricing.
Enterprise Readiness
KardiaAIKardiaAI demonstrates stronger enterprise readiness through its design as an API library and SDK, enabling flexible integration into various mobile apps, web platforms, and existing EHR systems like Epic and GE Healthcare's MUSEu2122 NX. Both tools are HIPAA compliant and offer BAAs, but KardiaAI's component-based approach provides greater adaptability for custom enterprise solutions and workflows [JSON, 49].
Innovation
Eko Analysis SoftwareEko Analysis Software leads in innovation by uniquely integrating advanced digital auscultation with ECG and AI for both heart murmur and arrhythmia detection, effectively transforming a traditional diagnostic instrument into a smart tool. This dual-modality approach and continuous development of algorithms for broader disease detection represent a significant advancement in point-of-care diagnostics.
Support & Docs
TieBoth Eko Analysis Software and KardiaAI offer comprehensive support resources, including online help centers, user manuals, troubleshooting guides, and direct contact options via phone and email. While AliveCor highlights an accessibility statement and document conversion services, Eko provides dedicated support for enterprise clients, resulting in a balanced offering without a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | KardiaAI |
|---|---|---|
| Name | Eko Analysis Software | KardiaAI |
| Company | Eko Devices | AliveCor |
| Description | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Key AI Detections | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm | Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm, Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs), Detection of Sinus Rhythm with Wide QRS, Detection of Sinus Rhythm with Supraventricular Ectopy (SVE) |
| Primary Data Input | Wireless auscultation with Bluetooth-enabled devices (heart sounds and ECGs) | Ambulatory ECG rhythms |
| Integration | Integrates with Eko's digital stethoscopes and mobile app | API library for integration into other ECG devices and software |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Analysis Software or KardiaAI
Backers
Who funded each tool's parent company.